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Use of fenestrated-branched endovascular aneurysm repair to
treat Carrel patch aneurysmal degeneration after open
thoracoabdominal aortic aneurysm repair
Tammy T. Nguyen, MD, PhD, Jessica P. Simons, MD, MPH, and Andres Schanzer, MD, Worcester, Mass
ABSTRACT
Two patients with a history of open type II thoracoabdominal aortic aneurysm repair presented with saccular aneurysmal
degeneration of the Carrel patch. The degenerated segments measured 6.2 cm and 7.4 cm, respectively, and involved the
celiac artery, superior mesenteric artery, and right renal artery. Both patients successfully underwent a custom
fenestrated-branched endovascular aneurysm repair with downgoing branches to the celiac artery, superior mesenteric
artery, and right renal artery and a stented fenestration to the left renal artery. Completion angiography demonstrated no
endoleak and patent visceral-renal segments. Both patients were discharged home on postoperative day 2. (J Vasc Surg
Cases and Innovative Techniques 2019;5:117-21.)
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Open surgical repair of type II thoracoabdominal aortic
aneurysm (TAAA) requires visceral-renal vessel revascu-
larization.1-6 The Carrel patch technique accomplishes
this by using a full-thickness patch of aortic tissue con-
taining several oriﬁces of the visceral arteries. This Carrel
patch most commonly includes the origins of the celiac
artery (CA), superior mesenteric artery (SMA), and right
renal artery (RRA) and is sutured to the aortic graft in
an end-to-side fashion. Whereas this strategy is highly
efﬁcient, minimizing ischemia time and technical
complexity, the segment of retained native aorta is prone
to recurrent aneurysmal disease in approximately 4% to
7.5% of patients.2,3,7-9 In fact, Carrel patch aneurysmal
degeneration is one of the most common indications
for reintervention after open TAAA repair.1,7,8,10 Given
that open repair for Carrel patch aneurysm is associated
with a 40% mortality, alternative repair strategies with
decreased morbidity and mortality represent a signiﬁ-
cant unmet need.1,7,8
Currently, fenestrated-branched endovascular aneu-
rysm repair (F/B-EVAR) is used in the United States, in
the context of Food andDrug Administration (FDA)-spon-
sored investigational device exemption (IDE) trials, to treat
TAAA in patients who are at high risk for open repair.11-15
Whereas off-the-shelf and physician-modiﬁed designs
confer certain advantages, company-manufactured,
custom-made devices are well suited to endovascular
repair of Carrel patch aneurysms.11-13,16 In cases of prior
open repair, in which reimplantation and patch degener-
ation often lead to signiﬁcant distortions of the normal
anatomic conﬁguration, custom-made F/B-EVAR can be
designed to be patient speciﬁc and to accommodate a
variety of branch vessel anatomy. We report two cases
using company-manufactured, custom-made F/B-EVAR
to treat aneurysmal degeneration of Carrel patches after
open TAAA repair. The patients described have consented
to participation in our FDA-approved IDE clinical trial (IDE
#G130210) and to the publication of this article.
CASE REPORT
Patient A is an 87-year-old womanwith a history of open type II
TAAA repair in 2009, with a Carrel patch involving the CA, SMA,
and RRA and a separate bypass to the left renal artery (LRA).
During routine computed tomography angiography (CTA) sur-
veillance, the patient was found to have degeneration of the
Carrel patch, resulting in a saccular aneurysm measuring
7.4 cm in maximum diameter (Fig 1, A).
Patient B is a 35-year-old man with a history of open type II
TAAA repair in 2010, with a Carrel patch for the CA, SMA, and
RRA and reimplantation of the LRA. His aneurysm was associ-
ated with a history of ACTA2 autosomal dominant genetic
mutation and a chronic type B aortic dissection. During routine
CTA surveillance, the patient was found to have degeneration of
the Carrel patch, resulting in a saccular aneurysm measuring
6.2 cm in maximum diameter (Fig 1, B).
Patients A andBwere referred to theUMassMemorial Center for
ComplexAorticDisease for evaluation forminimally invasive repair.
Both patients successfully underwent F/B-EVAR with a custom-
made, company-manufactured device with downgoing branches
to the CA, SMA, and RRA and a stented small fenestration to the
LRA. All repairs were planned on the basis of measurements ob-
tained from high-resolution CTA images on a three-dimensional
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workstation using standard centerline ﬂoworthogonal techniques
(TeraRecon, Foster City, Calif). Custom-made F/B-EVARgrafts were
manufactured using the Cook endograft platform (Cook Medical,
Bloomington, Ind). Both repairswere performedusing a single sur-
gically exposed femoral artery access site and a single surgically
exposed axillary artery access site (through an infraclavicular inci-
sion). Themainbody F/B-EVARgraftwasdesignedwith amodiﬁed
preloadeddelivery systemusinga preloadedcannulation catheter
for the left renal fenestration. This preloading design enabled can-
nulation and bridging stent graft placement through the delivery
system from the ipsilateral groin access site (Fig 2). The CA, SMA,
and RRA were cannulated from the open right axillary artery
exposure. The advantage of accessing the right axillary artery is
an ergonomic one because the C-arm is positioned to the left of
the patient, and all other aspects of the operation are performed
with the surgeon at the patient’s right side. Because no clinical
consequences of this approach have been identiﬁed, these
advantages justify its use. No strokes occurred during the 30-day
follow-up period. Balloon-expandable stent grafts (iCast; Atrium,
Hudson, NH) were used as bridging stents for all target arteries. It
is our practice not to reline iCast balloon-expandable stent grafts
with self-expanding stents, given the relative baseline stiffness
and radial force of an iCast stent graft. Conversely, Viabahn stent
grafts (W. L. Gore & Associates, Flagstaff, Ariz) are highly ﬂexible
with less radial force. As a result, most centers that use Viabahn
stent grafts choose to reline Viabahn branches. In our opinion,
this is perfectly reasonable, but it does increase cost, number of
components used, and technical complexity. The literature
supports the use of either strategy for branches, with neither being
established as superior to the other.
Completion angiography showed excellent stent graft archi-
tecture with no kinks or component separations, no evidence
of endoleak, and patent visceral branches (Fig 3). Total operative
time was 4 hours and 6 minutes for patient A and 4 hours and
19 minutes for patient B. Postoperative courses were uneventful
for both patients, with discharge to home on postoperative day
2. On 1-month surveillance imaging, both repairs were found to
be intact with complete aneurysm exclusion and all target
arteries patent (Fig 4). Patient B’s 1-month CTA surveillance
demonstrated a type II endoleak that is likely to be due to reim-
planted intercostal arteries during the initial open repair and
two lumbar branches that are distal to the original open surgical
repair. We plan to observe and to monitor the type II endoleak
with serial CTA imaging. If the endoleak persists and the aneu-
rysm sac expands over time, we will then treat the endoleak
with translumbar coil embolization.
DISCUSSION
Open TAAA repair requires revascularization of visceral
and renal vessels, which is commonly accomplished
using the Carrel patch technique.17 This surgical tech-
nique reduces the number of anastomoses and allows
expeditious repair.1-6,18 However, the retained native
aortic tissue may continue to degenerate over time,
resulting in a Carrel patch aneurysm. In one report, the
mean time from TAAA repair to visceral patch aneurysm
Fig 1. Preoperative three-dimensional model of aneurysmal degeneration of the Carrel patch in patient A (A),
resulting in a saccular aneurysm measuring 7.4 cm in maximum diameter, and patient B (B), resulting in a
saccular aneurysm measuring 6.2 cm in maximum diameter. The scale bar is 50 mm. CA, Celiac artery; RRA,
right renal artery; SMA, superior mesenteric artery.
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detection was 6.5 years.7-9 Patients with known connec-
tive tissue disorders have an 18% incidence of Carrel
patch aneurysm, whereas a 5.6% incidence of Carrel
patch aneurysm is reported in patients with degenera-
tive aneurysms without connective tissue disorder.6-8,10
The natural history of Carrel patch aneurysms, including
growth rate and risk of rupture, is unknown. However,
because of the saccular morphology of Carrel patch an-
eurysms, they are considered to have a higher risk of
rupture than fusiform aneurysms, and ruptures have
been reported to occur at a diameter >6 cm.4,5,7-9,19
Open repair of Carrel patch aneurysm is associated with
a 40%mortality rate due to factors including the technical
difﬁculty of redo surgical dissection and inﬂammation
around the previous repair.1,7,8 These repairs often require
cardiopulmonary bypass and are associated with long
operative times, signiﬁcant blood loss, and prolonged
lengths of stay in the intensive care unit.7-9
Endovascular exclusion techniques have been
described as a successful treatment option for recurrent
aneurysmal degeneration after open TAAA repair. Inter-
costal patch and thoracic aorta graft anastomosis aneu-
rysmal degeneration after open TAAA repair have been
excluded by using aortic endografts.10,20 Although
minimally invasive, this approach resulted in the sacri-
ﬁce of all patent intercostals in that segment; however,
no spinal cord ischemia complications occurred. Unlike
intercostal patch aneurysms, Carrel patch aneurysms
cannot be treated with standard endografts that
exclude the visceral and renal aorta because this
will result in end-organ ischemia. Two previous case
reports from other countries have described the use of
F/B-EVAR for pseudoaneurysms in the visceral
segment after TAAA repair.21,22 One report described a
four-fenestration design, employed to treat pseudoa-
neurysm at the CA origin.21 Performed in 2012, the pro-
cedure time was 5 hours, and the hospital stay was
8 days; 18-month imaging revealed an intact repair
with regression of the aneurysm sac. The other report
described a three-branch design (the LRA was chroni-
cally occluded) to treat a recurrent Carrel patch aneu-
rysmal degeneration after a redo open TAAA repair
done previously for initial patch aneurysmal degenera-
tion.22 Performed in 2006, the procedure time was
12 hours, and the hospital stay was 13 days; 12-month
imaging revealed an intact repair. These reports, along
with ours, demonstrate that custom-made company-
manufactured F/B-EVAR is a safe and effective mini-
mally invasive treatment option for Carrel patch
aneurysmal degeneration.
As experience with complex endovascular aneurysm
repair has grown, its application to Carrel patch aneu-
rysm has been proposed to mitigate some of the
morbidity and mortality of open repair and the limita-
tions of conventional endovascular repair. Our approach,
using custom-made, company-manufactured F/B-EVAR,
Fig 2. Custom-made fenestrated-branched endovascular
aneurysm repair (F/B-EVAR) design and corresponding
graft. A, Patient A custom-made F/B-EVAR design. B, Pa-
tient A F/B-EVAR graft. C, Patient B preoperative custom-
made F/B-EVAR design. D, Patient B F/B-EVAR graft.
RRA, Right renal artery; RT, right; SMA, superior mesenteric
artery. The red ellipse indicates anterior marker, and the
blue ellipse indicates tick marker; Ø is diameter in milli-
meters. All numbers are in millimeters.
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addressed these challenges, with good technical success
and short-term outcomes. However, the midterm and
long-term durability of this treatment strategy must be
evaluated; per our protocol, these patients are evaluated
at 6 and 12 months postoperatively and annually there-
after with CTA. This is especially true for young patients
with connective tissue disorders, such as patient B, who
have many years of life ahead of them in which long-
term durability is critical if we are to deem this strategy
successful. Based on our experience, within the context
of an FDA-approved IDE clinical trial at a high-volume
center with rigorous follow-up, the role of F/B-EVAR
can safely be extended to include patients with Carrel
patch aneurysm.
Fig 3. Intraoperative three-dimensional reconstruction of fenestrated-branched endovascular aneurysm repair
(F/B-EVAR) after stent graft deployment in patient A (A) and patient B (B).
Fig 4. The 1-month three-dimensional reconstruction of fenestrated-branched endovascular aneurysm repair
(F/B-EVAR) graft in patient A (A) and patient B (B). The scale bar is 50 mm. CA, Celiac artery; RRA, right renal
artery; SMA, superior mesenteric artery.
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CONCLUSIONS
Aneurysmal degeneration of Carrel patches in patients
withprevious open TAAA repair canbe successfully treated
with F/B-EVAR. Custom-made, company-manufactured
endografts offer the widest diversity of device conﬁgura-
tions to address anatomy that can be extremely variable
in patients with Carrel patch aneurysms.
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